Not Only RET but NF1 and Chromosomal Instability Are Seen in Young Patients with Sporadic Medullary Thyroid Carcinoma

Autor(es):Mostrar menos -

Castroneves, Luciana Audi ; Mangone, Flavia Regina Rotea ; Lerario, Antonio Marcondes ; da Cunha Mercante, Ana Maria ; Batista, Rafael Loch ; Barros, Luciana Rodrigues Carvalho ; Ferreira, Carla Vaz ; Farias, Evelin Cavalcante ; Vanderlei, Felipe Augusto Brasileiro ; Maia, Ana Luiza ; Nagai, Maria Aparecida ; Jorge, Alexander Augusto Lima ; Hoff, Ana Oliveira

• Tipo de documento: Artigo Científico
• Fonte: JOURNAL OF THE ENDOCRINE SOCIETY; v. 8, n. 6, p. 8-pg., 2024-04-06.

Resumo

Context Genetic analysis of sporadic medullary thyroid carcinoma (MTC) has revealed somatic variants in RET, RAS, and occasionally other genes. However, around 20% of patients with sporadic MTC lack a known genetic driver.Objective To uncover potential new somatic or germline drivers, we analyze a distinct cohort of patients with sporadic, very early-onset, and aggressive MTC.Methods Germline and somatic DNA exome sequencing was performed in 19 patients, previously tested negative for germline RET variants.Results Exome sequencing of 19 germline samples confirmed the absence of RET and identified an NF1 pathogenic variant in 1 patient. Somatic sequencing was successful in 15 tumors revealing RET variants in 80%, predominantly p.Met918Thr, which was associated with disease aggressiveness. In RET-negative tumors, pathogenic variants were found in HRAS and NF1. The NF1 germline and somatic variants were observed in a patient without a prior clinical diagnosis of neurofibromatosis type 1, demonstrating that the loss of heterozygosity of NF1 functions as a potential MTC driver. Somatic copy number alterations analysis revealed chromosomal alterations in 53.3% of tumors, predominantly in RET-positive cases, with losses in chromosomes 9 and 22 being the most prevalent.Conclusion This study reveals that within a cohort of early-onset nonhereditary MTC, RET remains the major driver gene. In RET-negative tumors, NF1 and RAS are drivers of sporadic MTC. In addition, in young patients without a RET germline mutation, a careful clinical evaluation with a consideration of germline NF1 gene analysis is ideal to exclude Neurofibromatosis type 1 (NF1). (AU)

• Processo FAPESP: 19/20300-5 - Avaliação clínica e molecular do Carcinoma Medular da Tireoide esporádico em jovens
• Beneficiário: Ana Amélia Fialho de Oliveira Hoff
• Modalidade de apoio: Auxílio à Pesquisa - Regular